COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring. |
University of Cambridge > Talks.cam > Isaac Newton Institute Seminar Series > Genome sequencing of Leishmania donovani clinical lines reveals dynamic phylogenetic variation
Genome sequencing of Leishmania donovani clinical lines reveals dynamic phylogenetic variationAdd to your list(s) Download to your calendar using vCal
If you have a question about this talk, please contact Mustapha Amrani. Phylogenetics Leishmaniases are a range of debilitating neglected parasitic illnesses that have several forms: cutaneous, mucocutaneous and most potently, the visceral, which has a global incidence of approximately half a million cases per year. Consequently, a range of early-detection and treatment programs are implemented to limit the spread of the disease, but these are forced to combat the emergence of drug resistance in patients. The causative agent of visceral leishmanisis, the species of the Leishmania donovani complex, is found most frequently in equatorial regions and has a range from southern Europe to Africa to southern Asia. This presentation focuses on distinct regions of India and Nepal where the pathogen displays extensive variation in its response to the drugs most commonly used in treatment. Despite a low level of genetic diversity, clinical samples of these parasites manifest pronounced differences in phenotype. We sequenced, assembled and annotated the genome sequence fo r L. donovani, and used this as a basis for exploring variation in 17 samples cloned from patients with varying treatment outcomes. Many layers of diversity between these genome-sequenced strains were evident at the level of single DNA nucleotides, repetitive gene copies, whole chromosome duplications and extra-chromosomal fragments. By combining this population-level picture with the other sequenced Leishmania species genomes, candidate variants relevant to drug resistance were identified. This study provides evidence of the power and scope of genome-level surveillance of emergent drug resistance in pathogens. This talk is part of the Isaac Newton Institute Seminar Series series. This talk is included in these lists:
Note that ex-directory lists are not shown. |
Other listsepiSTEMe dissemination event Graduate Women's Network Clare Hall Lecture: The evolution of Abcam plc - 30 April 2013Other talksCambridge - Corporate Finance Theory Symposium September 2017 - Day 1 Epigenetics - Why DNA Is Not Your Destiny Epigenetics: One Genome, Multiple Phenotypes The spin evolution of supermassive black holes CANCELLED Jennifer Luff: Secrets, Lies, and the 'Special Relationship' in the Early Cold War Systems for Big Data Applications:Revolutionising personal computing Market Socialism and Community Rating in Health Insurance A feast of languages: multilingualism in neuro-typical and atypical populations mTORC1 signaling coordinates different POMC neurons subpopulations to regulate feeding The Partition of India and Migration Mathematical applications of little string theory Grammar Variational Autoencoder |